1. Validation of Biopharmaceutical Purification Processes for Virus Clearance Evaluation
2. Guidance on Viral Safety Evaluation of Biotechnology Products Derived from Cell Lines of Human or Animal Origin Q5A. Paper presented at: International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use. Geneva Switzerland;1998.
3. World Health Organization. Guidelines on viral inactivation and removal procedures intended to assure the viral safety of human blood plasma products. World Health Organization. WHO Technical Report Series No 924; 2004.